The importance of including patient voices when appraising new drug treatments for strokes is backed by meta-analyses of several studies.
https://t.co/o2s6vbT0HC
New in @eLife 🧠
CCR5 antagonists show promise for stroke treatment in preclinical studies — but the evidence has gaps.
Our patient-led systematic review reveals opportunities & limitations for clinical translation.
🧪➡️👥
Read more: https://t.co/0Zvqq87PA7
#StrokeRecovery#CCR5
We're excited to be sharing another edition of our LabPartners newsletter, highlighting our work to champion patient engagement in preclinical laboratory-based research! Read the full newsletter here: https://t.co/R33oaI6Gzz
You can also hear our PhD candidate, Matthew Jeffers, speak about this work at Plenary 3 of the @StemCellNetwork#TMM2024 meeting on November 5 in Montreal. Hope to see you there!
Interested in what #preclinical 🐭 evidence is needed to advance your new #celltherapy 🔬 into #clinicaltrials 👩🔬? We synthesized key guidance from over 60 regulatory agencies worldwide to help accelerate your research. https://t.co/3h3ZK5lgvM
Interested in what #preclinical 🐭 evidence is needed to advance your new #celltherapy 🔬 into #clinicaltrials 👩🔬? We synthesized key guidance from over 60 regulatory agencies worldwide to help accelerate your research. https://t.co/3h3ZK5lgvM
We're excited to be sharing the second edition of our LabPartners newsletter, highlighting our work to champion patient engagement in preclinical laboratory-based research! Read the full newsletter here: https://t.co/pFIs3vPnH6
The Blueprint Translational Research Team at the Ottawa Hospital Research Institute has created a policy brief outlining how patient engagement can be promoted in preclinical laboratory-based research! Read the full policy brief HERE: https://t.co/QJHKubcIlB
The Blueprint Team is excited to be launching a newsletter focused on our program to facilitate patient engagement in preclinical laboratory research! Available here: https://t.co/CQSYeRFhXn
The Blueprint Team is excited to be launching a newsletter focused on our program to facilitate patient engagement in preclinical laboratory research! Available here: https://t.co/CQSYeRFhXn
Dr. Michael Verret's work was highlighted in the SPOR December newsletter. What an excellent example of patient engagement in opioid minimization research! 🎉 https://t.co/s5OYgbY8K4
@BenjaminNHLam had the opportunity to attend the Post Graduate Assembly in Anesthesiology #PGA77 conference in New York City and presented his research! 🎉Way to go Benjamin!
Dr. Ulf Tölch, visiting scientist from Berlin, is presenting this Friday Dec 15 @ 1pm (in-person). If you have interest in designing preclinical studies in order to help increase potential for translation to human research, you won't want to miss this presentation!
Un grand bravo aux boursiers #VanierCanada 2023 de l’@uOttawa qui cherchent à développer des solutions proactives en santé et à améliorer notre qualité de vie grâce à leurs projets de recherche novateurs. Félicitations!
A round of applause for @uOttawa’s 2023 #VanierCanada Scholars who are striving to develop proactive health solutions and improve our quality of life through their innovative research projects. Congratulations to all!